MiR-19b promotes tumor growth and metastasis via targeting TP53

RNA

Volumn 20, Issue 6, 2014, Pages 765-772

  Fan, Yu ^a   Yin, Shenyi ^a   Hao, Yang ^a   Yang, Junyu ^a   Zhang, Hanshuo ^a   Sun, Changhong ^a   Ma, Ming ^a   Chang, Qing ^a   Xi, Jianzhong Jeff ^a,b  

^a PEKING UNIVERSITY   (China)

^b Peking University   (China)

Author keywords

MiRNA; TP53; Tumor metastasis

Indexed keywords

ANTAGOMIR; MICRORNA; MICRORNA 19B; PROTEIN BAX; PROTEIN P53; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VIVO STUDY; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENESCENCE; TUMOR GROWTH;

MIRNA; TP53; TUMOR METASTASIS;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL CYCLE; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOWN-REGULATION; GENES, P53; HEK293 CELLS; HELA CELLS; HUMANS; MCF-7 CELLS; MICRORNAS; NEOPLASM METASTASIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84901468024     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.043026.113     Document Type: Article

References (25)

1. Bartel DP. 2004. MicroRNAs: genomics, biogenesis, mechanism, andfunction. Cell 116: 281-297.
2. Bennett WP, Hussain SP, Vahakangas KH, Khan MA, Shields PG,Harris CC. 1999. Molecular epidemiology of human cancer risk:gene-environment interactions and p53 mutation spectrum in humanlung cancer. J Pathol 187: 8-18. (Pubitemid 29009831)
3. Chao C, Herr D, Chun J, Xu Y. 2006. Ser18 and 23 phosphorylationis required for p53-dependent apoptosis and tumor suppression.EMBO J 25: 2615-2622.
4. Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD,Schuler M, Green DR. 2004. Direct activation of Bax by p53 mediatesmitochondrial membrane permeabilization and apoptosis. Science303: 1010-1014. (Pubitemid 38209704)
5. Galbiati F, Volonte D, Liu J, Capozza F, Frank PG, Zhu L, Pestell RG,Lisanti MP. 2001. Caveolin-1 expression negatively regulates cellcycle progression by inducing G0/G1 arrest via a p53/p21WAF1/Cip1-dependent mechanism. Mol Biol Cell 12: 2229-2244. (Pubitemid 33051953)
6. Gantier MP, Stunden HJ, McCoy CE, Behlke MA, Wang D, Kaparakis-Liaskos M, Sarvestani ST, Yang YH, Xu D, Corr SC, et al. 2012. AmiR-19 regulon that controls NF-κB signaling. Nucleic Acids Res40: 8048-8058.
7. Hamzehloie T, Mojarrad M, Hasanzadeh Nazarabadi M, Shekouhi S.2012. The role of tumor protein 53 mutations in common humancancers and targeting the murine double minute 2-p53 interactionfor cancer therapy. Iran J Med Sci 37: 3-8.
8. Hollstein M, Sidransky D, Vogelstein B, Harris CC. 1991. p53 mutationsin human cancers. Science 253: 49-53.
9. Hu W, Chan CS, Wu R, Zhang C, Sun Y, Song JS, Tang LH, Levine AJ,Feng Z. 2010. Negative regulation of tumor suppressor p53 bymicroRNA miR-504. Mol Cell 38: 689-699.
10. Kumar M, Lu Z, Takwi AA, Chen W, Callander NS, Ramos KS,Young KH, Li Y. 2011. Negative regulation of the tumor suppressorp53 gene by microRNAs. Oncogene 30: 843-853.
11. Le MT, Teh C, Shyh-Chang N, Xie H, Zhou B, Korzh V, Lodish HF,Lim B. 2009. MicroRNA-125b is a novel negative regulator of p53.Genes Dev 23: 862-876.
12. Lee Y, Samaco RC, Gatchel JR, Thaller C, Orr HT, Zoghbi HY.2008. miR-19, miR-101 and miR-130 co-regulate ATXN1 levels topotentially modulate SCA1 pathogenesis. Nature Neurosci 11:1137-1139.
13. Levine AJ, Momand J, Finlay CA. 1991. The p53 tumour suppressorgene. Nature 351: 453-456.
14. Li J, Donath S, Li Y, Qin D, Prabhakar BS, Li P. 2010. miR-30 regulatesmitochondrial fission through targeting p53 and the dynamin-relatedprotein-1 pathway. PLoS Genet 6: e1000795.
15. Liu D, Ou L, Clemenson GD Jr, Chao C, Lutske ME, Zambetti GP,Gage FH, Xu Y. 2010. Puma is required for p53-induced depletion of adult stem cells. Nat Cell Biol 12: 993-998.
16. Meylan E, Dooley AL, Feldser DM, Shen L, Turk E, Ouyang C, Jacks T.2009. Requirement for NF-κB signalling in a mouse model of lungadenocarcinoma. Nature 462: 104-107.
17. Murray-Zmijewski F, Slee EA, Lu X. 2008. A complex barcode underliesthe heterogeneous response of p53 to stress. Nat Rev Mol Cell Biol9: 702-712.
18. Olive V, Bennett MJ, Walker JC, Ma C, Jiang I, Cordon-Cardo C, Li QJ,Lowe SW, Hannon GJ, He L. 2009. miR-19 is a key oncogenic componentof mir-17-92. Genes Dev 23: 2839-2849.
19. Philippe L, Alsaleh G, Suffert G, Meyer A, Georgel P, Sibilia J,Wachsmann D, Pfeffer S. 2012. TLR2 expression is regulated by microRNA miR-19 in rheumatoid fibroblast-like synoviocytes. JImmunol 188: 454-461.
20. Smith ML, Ford JM, Hollander MC, Bortnick RA, Amundson SA,Seo YR, Deng CX, Hanawalt PC, Fornace AJ Jr. 2000. p53-mediated DNA repair responses to UV radiation: studies of mouse cells lackingp53, p21, and/or gadd45 genes. Mol Cell Biol 20: 3705-3714. (Pubitemid 30243916)
21. Tasdemir E, Maiuri MC, Galluzzi L, Vitale I, Djavaheri-Mergny M,D'Amelio M, Criollo A, Morselli E, Zhu C, Harper F, et al. 2008.Regulationof autophagy by cytoplasmic p53.NatCell Biol 10: 676-687.
22. Thomas A, Giesler T, White E. 2000. p53 mediates Bcl-2 phosphorylationand apoptosis via activation of the Cdc42/JNK1 pathway.Oncogene 19: 5259-5269.
23. Vopalensky V, Masek T, Horvath O, Vicenova B, Mokrejs M,Pospisek M. 2008. Firefly luciferase gene contains a cryptic promoter.RNA 14: 1720-1729.
24. Xu XM, Wang XB, Chen MM, Liu T, Li YX, Jia WH, Liu M, Li X,Tang H. 2012. MicroRNA-19a and -19b regulate cervical carcinomacell proliferation and invasion by targeting CUL5. Cancer Lett 322:148-158.
25. Yan HL, Xue G, Mei Q, Wang YZ, Ding FX, Liu MF, Lu MH, Tang Y,Yu HY, Sun SH. 2009. Repression of the miR-17-92 cluster by p53has an important function in hypoxia-induced apoptosis. EMBOJ 28: 2719-2732.